| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
39 |
| Employees |
75 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-98 |
| Cash Flow (TTM) (Millions $) |
-7 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Atreca Inc. is a biotechnology company based in Redwood City, California. The company specializes in the discovery and development of novel therapeutics using a unique discovery platform called Atreca Engine. This platform enables the identification and generation of antibodies targeting previously inaccessible and understudied regions of the human immune system.
Atreca focuses on developing therapies for various diseases, including cancer, autoimmune disorders, and infectious diseases. Their approach involves studying the immune responses of patients to identify and isolate antibodies that can effectively target specific disease-causing molecules.
By leveraging their proprietary technology, Atreca aims to develop precise and personalized immunotherapies that have the potential to improve patient outcomes. Their goal is to enhance the understanding of the human immune response and use this knowledge to develop innovative treatments that address unmet medical needs.
Overall, Atreca Inc. is dedicated to pioneering the discovery and development of next-generation therapeutics by harnessing the power of the human immune system.
Company Address: 835 Industrial Road, Suite 400 San Carlos 94070 CA
Company Phone Number: 595-2595 Stock Exchange / Ticker: NASDAQ BCEL
|
%
0.46%